Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analysis of desflurane blood concentration during cardiopulmonary bypass
jRCTs041190132Completed
- Sponsor
- Baxter International Inc.
- Start
- Mar 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of desflurane in Cardiac valve disease (VHD) and coronary arteriosclerosis, sponsored by Baxter International Inc. Primary endpoint: Blood concentration of desflurane 30 minutes after administration during CPB. Started Mar 2020; status: completed.
02
Drugs
desflurane
03
Conditions
Cardiac valve disease (VHD)coronary arteriosclerosis
Beyond the preview
Go deeper on jRCTs041190132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190132.